Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allergan Inc v. Merz Pharmaceuticals LLC et al
Case Number:
8:11-cv-00446
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 07, 2012
Judge Blocks Rival Botox Drug In Trade Secrets Trial
A California federal judge on Tuesday barred Merz Pharmaceuticals LLC from selling wrinkle-reducing drug Xeomin, just days before the Botox competitor's nationwide launch, in a bench trial over allegations the company's employees stole trade secrets from Botox maker and rival Allergan Inc.
-
January 30, 2012
Allergan, Merz Row Over Botox Secrets Headed To Trial
A California federal judge on Monday indicated that Merz Pharmaceuticals LLC and seven of its employees would have to defend themselves against allegations by Allergan Inc. that they used proprietary sales data for the wrinkle-reducing drug Botox to snag clients for a rival drug.